
GlaxoSmithKline Pharmaceuticals Share Price
₹2,260.65 +261.3 (13.07%)
07 Feb, 2025 07:53
Start SIP in
GLAXO
Performance
- Low
- ₹1,992
- High
- ₹2,364
- 52 Week Low
- ₹1,842
- 52 Week High
- ₹3,088
- Open Price₹2,000
- Previous Close₹1,999
- Volume2,465,345
Investment Returns
- Over 1 Month + 2.71%
- Over 3 Month -14.03%
- Over 6 Month -18.96%
- Over 1 Year -8.36%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.7
- PEG Ratio
- 13.5
- Market Cap Cr
- 38,297
- P/B Ratio
- 22.9
- Average True Range
- 88.05
- EPS
- 47.33
- Dividend Yield
- 1.9
- MACD Signal
- -63.42
- RSI
- 64.01
- MFI
- 70.2
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,260.65
+
261.3
(13.07%)

-
- Bearish Moving Average 5
-
- Bullish Moving Average 11
- 20 Day
- ₹2,074.22
- 50 Day
- ₹2,191.10
- 100 Day
- ₹2,320.18
- 200 Day
- ₹2,339.27
Resistance and Support
2205.55
- R3 2,791.10
- R2 2,577.55
- R1 2,419.10
- S1 2,047.10
- S2 1,833.55
- S3 1,675.10
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,260 As on 07 February, 2025 | 07:39
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹38296.8 Cr As on 07 February, 2025 | 07:39
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 56.7 As on 07 February, 2025 | 07:39
The PB ratio of GlaxoSmithKline Pharmaceuticals is 22.9 As on 07 February, 2025 | 07:39
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.